MedPath

Meiziya Kang L8 Capsules

Registration Number: MAL22046087TC

Approved
Approval ID

9dca7925b6277ef1

Registration Number

MAL22046087TC

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (1)

28 CapsulesAvailable
Package Size: 28 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (5)

Rehmannia GlutinosaActive
Lycium barbarumActive
Monograph: lycium barbarum
Chrysanthemum morifoliumActive
Monograph: chrysanthemum morifolium
Cornus officinalisActive
Dioscorea oppositaActive
Monograph: dioscorea opposita

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Meiziya Kang L8 Capsules - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform